We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

LNC Closes Successfully its Second Fundraising

News   Apr 12, 2012

 
LNC Closes Successfully its Second Fundraising
 
 
Advertisement
 

RELATED ARTICLES

Scientists Develop the First Known Methyl Transferase Ribozyme

News

The research group of chemistry professor Claudia Höbartner is now reporting a scientific breakthrough: Her team at Julius-Maximilians-Universität Würzburg (JMU) in Bavaria, Germany, has developed a ribozyme that can attach a very specific small chemical change at a very specific location in a target RNA.

READ MORE

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Biomarkers Could Be Used in Quick COVID-19 Blood Screening Strategy

News

A new study suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites. Three metabolites identified in the study could act as biomarkers and hold potential to be measured through an inexpensive blood test to quickly screen patients for the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE